The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and their impact on the outcome of patients with HR+/HER2+ metastatic breast cancer in a large real-world cohort.
 
Marcela Carausu
Travel, Accommodations, Expenses - Viatris
 
Matthieu Carton
No Relationships to Disclose
 
Veronique C Dieras
Honoraria - ABBVIE/ABBOTT; AstraZeneca; Daiichi Sankyo; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Seagen
Consulting or Advisory Role - ABBVIE/ABBOTT; AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Novartis; Pfizer; Roche; Seagen
 
Thierry Petit
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer; Pierre Fabre; Seagen
Travel, Accommodations, Expenses - Novartis; Novartis; Novartis; Pfizer; Pfizer; Pierre Fabre
 
Severine Guiu Lahaye
No Relationships to Disclose
 
Corinne Veyret
No Relationships to Disclose
 
Anthony Goncalves
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst)
 
Paule Augereau
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Novartis/Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; Novartis/Pfizer
 
Jean-Marc Ferrero
Consulting or Advisory Role - Daichi; Novartis; Pfizer
 
Christelle Levy
No Relationships to Disclose
 
Mony Ung
No Relationships to Disclose
 
Isabelle Desmoulins
No Relationships to Disclose
 
Marc Debled
No Relationships to Disclose
 
Thomas Bachelot
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; pfizer; Roche
 
Jean-Christophe Eymard
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - DAIICHI-SANKYO (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Novartis; Pfizer; Roche; Seagen
 
Michaël Chevrot
No Relationships to Disclose
 
Audrey Mailliez
Consulting or Advisory Role - DAICHII SANKYO; PFIZER; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pierre Fabre
 
Luc Cabel
No Relationships to Disclose